SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

GitLab, Inc. engages in the intelligent DevSecOps platform for software innovation. The firm enables organizations to increase developer productivity, improve operational efficiency, reduce security and compliance risk, and accelerate digital transformation. The company was founded by Dmitriy Zaporozhets and Sid Sijbrandij in 2011 and is headquartered in San Francisco, CA.

Gitlab Inc - Ordinary Shares - Class A

Gitlab Inc

Gitlab is trending following its earnings report, which showed a beat on Q4 revenue and non-GAAP EPS but delivered weaker-than-expected forward guidance. This has ignited a fierce debate in the community, with concerns over slowing growth and AI competition clashing against arguments for the company's strong fundamentals, buyback program, and AI integration tailwinds.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow with Knife ($CAW) is generating strong community buzz, frequently discussed as a multi-chain meme coin with an organic, decentralized approach and a deflationary burning mechanism, further fueled by its growing presence on platforms like Coinbase and Base.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending at multi-year highs amid intense anticipation for its pivotal Phase 3 REGAL trial results for GPS in AML, with strong community conviction in a groundbreaking outcome driving discussions of a potential buyout and a significant short squeeze.

Alibaba Group Holding Ltd. engages in providing technology infrastructure and marketing reach. It operates through the following business segments: China Commerce, International Commerce, Local Consumer Services, Cainiao, Cloud, Digital Media and Entertainment, and Innovation Initiatives and Others segments. The Core Commerce segment consists of platforms operating in retail and wholesale. The China Commerce segment includes China commerce retail and wholesale businesses. The International Commerce segment focuses on international commerce retail and wholesale businesses. The Local Consumer Services segment is involved in To-Home businesses, which include Ele.me, local services and delivery platform, and Taoxianda, and To-Destination segment businesses which include Amap, the provider of mobile digital map, navigation and real-time traffic information, and restaurant and local services guide platform. The Cainiao segment has Cainiao Network and offers domestic and international one-stop-shop logistics services and supply chain management solution. The Cloud segment includes Alibaba Cloud and DingTalk. The company was founded by Chung Tsai and Yun Ma on June 28, 1999 and is headquartered in Hangzhou, China.

Alibaba Group Holding Ltd - ADR

Alibaba Group Holding Ltd

Alibaba is trending amidst community debate over its persistently delayed earnings report date and a recently retracted Pentagon listing linking it to China's military. While many view the stock as oversold and undervalued with promising AI advancements, others remain cautious of ongoing geopolitical and regulatory uncertainties impacting the Chinese tech giant.

Circle Internet Group, Inc. is a financial technology company that enables businesses of all sizes to harness the power of digital currencies and public blockchains for payments, commerce and financial applications worldwide. The company was founded by Jeremy J. Allaire and Patrick Sean Neville in August 2013 and is headquartered in New York, NY.

Circle Internet Group Inc. - Ordinary Shares - Class A

Circle

Circle (CRCL) is experiencing significant momentum after its strong Q4 earnings highlighted robust growth in USDC circulation and on-chain transaction volume, with the community actively discussing its pivotal role as a foundational payment standard for AI agentic commerce, driving its rally as a key stablecoin infrastructure play.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is trending due to significant market volatility, as investors weigh strong fundamental tailwinds from soaring AI-driven memory demand and recent analyst upgrades against broader market contagion from geopolitical tensions impacting major South Korean chip competitors. This has created a polarized discussion, with bulls viewing the dip as a prime buying opportunity given Micron's robust HBM sales and upcoming earnings, while bears anticipate further correction amidst macro fears and profit-taking.

BlackRock Institutional Trust Company N.A. - iShares MSCI South Korea ETF

iShares MSCI South Korea ETF

The iShares MSCI South Korea ETF (EWY) is plummeting and experiencing market halts amid escalating Middle East tensions and surging oil prices, fueling widespread fear selling and deleveraging in what many describe as a "crowded retail trade." Conversely, some community members are actively discussing this as a strong "buy the dip" opportunity, citing resilient fundamentals for its key memory/AI chip holdings like Samsung and SK Hynix.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd is trending amid intense community debate, as a puzzling sell-off starkly contrasts with soaring crude oil prices and escalating Middle East tensions, prompting discussion of market manipulation, dilution, or a significant shakeout before a potential rally.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending as escalating Middle East tensions, including Iran's threats to the Strait of Hormuz, spark concerns over global oil supply and trigger a sharp sell-off across Asian markets, heavily impacting the semiconductor sector. Despite international market turmoil, traders are debating the Nasdaq's unusual intraday resilience, questioning if it can withstand geopolitical pressures or if a deeper correction is imminent.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as digital video compact disc player, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSM is hitting new highs, driven by stellar January revenue growth and its 2nm capacity being fully booked by top-tier clients, solidifying its indispensable role in the AI chip supercycle. The community widely views the company as the foundational "picks and shovels" leader despite persistent geopolitical uncertainties.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Esperion Therapeutics (NASDAQ:ESPR) Shares Down 13.1% - Should You Sell?

Esperion Therapeutics (NASDAQ:ESPR) Trading Down 13.1% - Here's What Happened...

Esperion Therapeutics (NASDAQ:ESPR) Given New $5.00 Price Target at Needham & Company LLC

Needham & Company LLC raised their price target on shares of Esperion Therapeutics from $4.00 to $5.00 and gave the stock a "buy" rating in a research note on Tuesday...

Esperion Therapeutics and Corstasis Therapeutics Announce Esperions Definitive Agreement to Acquire Corstasis, Expanding Its Cardiovascular Franchise with Enbumyst (bumetanide nasal spray)

Esperion (NASDAQ: ESPR) and Corstasis Therapeutics Inc., a privately-held, commercial-stage biopharmaceutical company advancing innovative outpatient therapies for the treatment of edema associated...

Esperion Therapeutics (ESPR) Earnings Expected to Grow: Should You Buy?

Esperion Therapeutics (ESPR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Esperion Therapeutics (ESPR) to Release Earnings on Tuesday

Esperion Therapeutics (NASDAQ:ESPR) will be releasing its Q4 2025 earnings before the market opens on Tuesday, March 3. (View Earnings Report at...

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Receives Average Recommendation of "Moderate Buy" from Analysts

Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the seven brokerages that are currently covering the stock, MarketBeat Ratings...

Esperion Therapeutics (NASDAQ:ESPR) Downgraded by Wall Street Zen to "Hold"

Wall Street Zen downgraded Esperion Therapeutics from a "buy" rating to a "hold" rating in a research report on Saturday...

Zacks Research Issues Optimistic Forecast for ESPR Earnings

Esperion Therapeutics, Inc. (NASDAQ:ESPR - Free Report) - Analysts at Zacks Research upped their Q4 2025 earnings estimates for Esperion Therapeutics in a research report issued on Tuesday, February...

Esperion Therapeutics (NASDAQ:ESPR) Raised to "Buy" at Wall Street Zen

Wall Street Zen raised Esperion Therapeutics from a "hold" rating to a "buy" rating in a research report on Saturday...

Esperion Therapeutics, Inc. (NASDAQ:ESPR) Given Average Recommendation of "Moderate Buy" by Brokerages

Esperion Therapeutics, Inc. (NASDAQ:ESPR - Get Free Report) has received a consensus rating of "Moderate Buy" from the eight ratings firms that are currently covering the company, Marketbeat.com...

Esperion Therapeutics, Inc. is a pharmaceutical company, which engages in the development and commercialization of oral therapies for elevated low-density lipoprotein cholesterol. The firm offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.

Esperion Therapeutics Inc.

Software / SaaS

Cybersecurity

Cloud Infrastructure

AI / Semiconductors

Which beaten-down sector are you buying first?

Stocktwits

Stocktwits Polls

Esperion acquired Corstasis for $75M cash, adding FDA-approved Enbumyst nasal spray for edema, prompting intense debate on its strategic fit and financial implications for the company.

Widespread investor frustration targets CEO Sheldon's leadership, criticizing his history of financial deals and the timing of the new acquisition amidst ongoing sales challenges.

Anticipation builds for imminent updates to cholesterol treatment guidelines, with investors hoping for a significant positive re-rating and demand boost for Esperion's core bempedoic acid franchise.

Following the acquisition news and a market downturn, investors are actively discussing current stock levels as a potential buying opportunity, while others weigh selling decisions.

Many users attribute the stock's recent decline not only to company-specific news but also to the general market downturn and geopolitical tensions like the situation with Iran.

ESPR
Esperion Therapeutics Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ESPR News

ESPREsperion Therapeutics Inc.